David C Corteville MD FACC, CPE
Echocardiography, Cardiothoracic Imaging, Non-Invasive Cardiology
Physician
Join to View Full Profile
101 Canal Landing BlvdSte 8Rochester, NY 14626
Phone+1 585-442-5320
Fax+1 585-227-7723
Dr. Corteville is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Cardiovascular Disease, 2008 - 2011
University of California (San Francisco)Residency, Internal Medicine, 2004 - 2007
University of Michigan Medical SchoolClass of 2004
Certifications & Licensure
CA State Medical License 2006 - Present
MI State Medical License 2008 - 2028
NY State Medical License 2020 - 2027
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
Publications & Presentations
PubMed
- Serotonin Norepinephrine Reuptake Inhibitor Is Associated With Lower Mortality Among Patients Presenting With Takotsubo Cardiomyopathy.Garba Rimamskep Shamaki, Anderson Anuforo, Israel Safiriyu, David Corteville, Monika Sanghavi
Journal of the American Heart Association. 2025-07-01 - A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ART...Marlies Ostermann, David C Corteville, Kent Doi, Jay L Koyner, Andre Lamy
Trials. 2025-05-30 - 1 citationsDevelopment of and recovery from acute kidney injury after cardiac surgery: Randomized phase 2 trial of the hepatocyte growth factor mimetic ANG-3777.Sabry S Ayad, Thomas Beaver, David Corteville, Madhav Swaminathan, Ronald G Pearl
The Journal of Thoracic and Cardiovascular Surgery. 2024-11-26
Press Mentions
Quark Pharmaceuticals, Inc. Phase 2 Data on the Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery to Be Presented at the American Society of Nephrology MeetingNovember 1st, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
